Several potential mechanisms of sorafenib resistance have been proposed to date, including epidermal growth factor receptor (EGFR) activation, c-Jun activation, autophagy, protein kinase B (AKT) activation, hypoxic environment, dysregulation of apoptosis, cancer stem cell renewal and epithelial-mesenchymal transition (EMT) [7]. Here, AKT1 is linked to cancer.